Physician profile

Grayson A Moore

Orthopaedic Surgery · Dripping Springs, TX

NPI 1245466457

$17,606.56

in general payments reported to CMS, 2019-2025

44 companies · $3,407 in 2025

The $3,407 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$4,445.62
Food and Beverage$2,315.90
Travel and Lodging$847.23

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Djo, LLC $8,361.65 2020-2025 Procare
Zimmer Biomet Holdings, INC. $1,713.97 2019-2025 Comprehensive Shoulder System, Tapestry, Gel-One Cross-Linked Hyaluronate
Sonex Health, INC. $1,303.02 2025 Sx-One Microknife
Medinc of Texas $1,200.00 2022
Radius Health, INC. $734.02 2019-2025 Tymlos
Smith+Nephew, INC. $578.60 2019-2025 Real Intelligence, Anthology, Journey II
Ferring Pharmaceuticals INC. $477.38 2019-2025 Euflexxa
Si-Bone, INC. $428.59 2021-2022
Abbott Laboratories $302.84 2019-2023 Proclaim
Orthalign INC $248.31 2021
Bioventus LLC $176.70 2019-2025 Durolane, Xcell, Durolane
Sanara Medtech INC. $167.00 2022
Core Surgical Group $154.11 2025
Depuy Synthes Sales INC. $148.27 2019-2023 Orthovisc, Monovisc
Orthofix Medical, INC. $144.18 2019-2024 Physio-Stim, Spinal-Stim
Show all 44 companies
CompanyGeneral paymentsYearsTop products
Stryker Corporation $133.66 2020-2024 1788
Catalyst Orthoscience $127.37 2022
Anika Therapeutics, INC. $122.65 2021-2024 Integrity, Tactoset
Terumo Bct, INC. $114.46 2019-2021
Mimedx Group, INC. $79.37 2025
Tenex Health INC. $75.44 2021
Ossio INC $72.04 2022-2023
Orthogenrx INC. $69.72 2019
Horizon Therapeutics Plc $60.74 2019-2022
Vertex Pharmaceuticals Incorporated $59.96 2025
Pacira Therapeutics, INC. $54.71 2019-2021
Ermi LLC $53.88 2019-2023
Heraeus Medical, LLC. $53.33 2019-2022
Kci USA, INC. $47.90 2023 Prevena
Zyla Life Sciences, INC. $43.83 2020
Medacta USA, INC. $37.15 2022-2023 Reverse Shoulder
Fidia Pharma USA INC. $33.28 2021-2025 Hymovis, Triluron
Kerecis Limited $28.91 2025 Kerecis Surgiclose, Kerecis Graftguide
Redhill Biopharma INC. $24.89 2020
Heron Therapeutics, INC. $23.12 2021
Skeletal Dynamics INC $20.68 2019
Baudax Bio INC. $20.34 2021
Pacira Pharmaceuticals Incorporated $18.49 2025 Exparel
Treace Medical Concepts, INC. $17.06 2025
Paragon 28, INC. $16.84 2019
Arthrosurface Incorporated $16.83 2020
Osteocentric Technologies, INC. $16.80 2019
Lilly USA, LLC $14.05 2024 Omvoh
Spinesmith Holdings, LLC $10.42 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Grayson A Moore

$17,606.56

in general payments reported 2019-2025

Years
2019-2025
Top company
Djo, LLC
Context
The $3,407 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).

https://glasscript.com/doctor/1329556/grayson-a-moore

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.